Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
39 participants
OBSERVATIONAL
2017-05-15
2018-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genetic Analysis in Diagnosing Thyroid Cancer in Patients With Thyroid Nodules
NCT00316823
Pembrolizumab in High-risk Thyroid Cancer
NCT05852223
Studies on Tumors of the Thyroid
NCT00001160
Protein Classifier for Thyroid Indeterminate Nodules
NCT04477798
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
NCT03676647
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Papillary carcinoma, classical variant
Immunohistochemistry
Immunohistochemistry procedure on the formalin-fixed, paraffin-embedded tissue.
Follicular carcinoma
Immunohistochemistry
Immunohistochemistry procedure on the formalin-fixed, paraffin-embedded tissue.
Colloid nodule
Immunohistochemistry
Immunohistochemistry procedure on the formalin-fixed, paraffin-embedded tissue.
Hyperplastic nodule
Immunohistochemistry
Immunohistochemistry procedure on the formalin-fixed, paraffin-embedded tissue.
Adenomatoid nodule
Immunohistochemistry
Immunohistochemistry procedure on the formalin-fixed, paraffin-embedded tissue.
Follicular adenoma
Immunohistochemistry
Immunohistochemistry procedure on the formalin-fixed, paraffin-embedded tissue.
Papillary carcinoma, follicular variant
Immunohistochemistry
Immunohistochemistry procedure on the formalin-fixed, paraffin-embedded tissue.
Medullary carcinoma
Immunohistochemistry
Immunohistochemistry procedure on the formalin-fixed, paraffin-embedded tissue.
Lymphocytic thyroiditis
Immunohistochemistry
Immunohistochemistry procedure on the formalin-fixed, paraffin-embedded tissue.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Immunohistochemistry
Immunohistochemistry procedure on the formalin-fixed, paraffin-embedded tissue.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* History of subtotal or total thyroidectomy at the "Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre hospitalier universitaire de Sherbrooke" (CIUSSS de l'Estrie - CHUS) between January 2010 and May 2016.
Exclusion Criteria
* Unavailability of the formalin-fixed, paraffin-embedded tissues.
* Uncertain pathological diagnosis.
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Robert Day
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Robert Day
PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert Day, PhD
Role: PRINCIPAL_INVESTIGATOR
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CIUSSS de l'Estrie - CHUS
Sherbrooke, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Fradet L, Temmar R, Couture F, Belzile M, Fortier PH, Day R. Evaluation of PACE4 isoforms as biomarkers in thyroid cancer. J Otolaryngol Head Neck Surg. 2018 Oct 19;47(1):63. doi: 10.1186/s40463-018-0311-x.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-1620
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.